1. Home
  2. DEVS vs ICCC Comparison

DEVS vs ICCC Comparison

Compare DEVS & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DEVS
  • ICCC
  • Stock Information
  • Founded
  • DEVS N/A
  • ICCC 1982
  • Country
  • DEVS Canada
  • ICCC United States
  • Employees
  • DEVS N/A
  • ICCC N/A
  • Industry
  • DEVS
  • ICCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • DEVS
  • ICCC Health Care
  • Exchange
  • DEVS NYSE
  • ICCC Nasdaq
  • Market Cap
  • DEVS 16.5M
  • ICCC 28.0M
  • IPO Year
  • DEVS N/A
  • ICCC 1987
  • Fundamental
  • Price
  • DEVS $0.81
  • ICCC $4.75
  • Analyst Decision
  • DEVS
  • ICCC
  • Analyst Count
  • DEVS 0
  • ICCC 0
  • Target Price
  • DEVS N/A
  • ICCC N/A
  • AVG Volume (30 Days)
  • DEVS 5.0M
  • ICCC 17.4K
  • Earning Date
  • DEVS 02-12-2025
  • ICCC 02-25-2025
  • Dividend Yield
  • DEVS N/A
  • ICCC N/A
  • EPS Growth
  • DEVS N/A
  • ICCC N/A
  • EPS
  • DEVS N/A
  • ICCC N/A
  • Revenue
  • DEVS N/A
  • ICCC $23,838,001.00
  • Revenue This Year
  • DEVS N/A
  • ICCC N/A
  • Revenue Next Year
  • DEVS N/A
  • ICCC N/A
  • P/E Ratio
  • DEVS N/A
  • ICCC N/A
  • Revenue Growth
  • DEVS N/A
  • ICCC 46.37
  • 52 Week Low
  • DEVS $0.48
  • ICCC $3.34
  • 52 Week High
  • DEVS $1.91
  • ICCC $5.82
  • Technical
  • Relative Strength Index (RSI)
  • DEVS N/A
  • ICCC 57.24
  • Support Level
  • DEVS N/A
  • ICCC $4.38
  • Resistance Level
  • DEVS N/A
  • ICCC $4.88
  • Average True Range (ATR)
  • DEVS 0.00
  • ICCC 0.42
  • MACD
  • DEVS 0.00
  • ICCC -0.03
  • Stochastic Oscillator
  • DEVS 0.00
  • ICCC 25.69

About DEVS DEVVSTREAM CORP

DevvStream Corp is a technology based ESG company that advances the development and monetization of environmental assets, with an initial focus on carbon markets. It works with governments and corporations to achieve their sustainability goals through the implementation of curated green technology projects that generate renewable energy, improve energy efficiencies, eliminate or reduce emissions, and sequester carbon directly from the air.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: